Monopar Therapeutics (MNPR) Share-based Compensation (2017 - 2025)
Monopar Therapeutics' Share-based Compensation was $1.1 million in Q4 2025, down 70.1% from $3.69 million a year earlier but up 0.4% from the prior quarter.
Monopar Therapeutics (MNPR) Share-based Compensation (2017 - 2025) Analysis & Trends
For FY2025, Share-based Compensation at Monopar Therapeutics came in at $4.84 million, up 6.3% from FY2024.
- Share-based Compensation has now increased for eight consecutive years, with a five-year compound annual growth rate of 29.6% (FY2020 to FY2025).
- In earlier years, Share-based Compensation was $4.55 million in FY2024 (+139.9%), $1.9 million in FY2023 (+15.6%), $1.64 million in FY2022 (+11.8%) and $1.47 million in FY2021 (+11.1%).
- Quarterly Share-based Compensation has moved between $199,122 (Q3 2024) and $3.69 million (Q4 2024) over five years.
- Compared with a year earlier, Share-based Compensation was higher in four of the last eight quarters, with growth averaging 192.1%.
- The best year-over-year quarter for Share-based Compensation over five years was Q4 2024 (growth of 678.2%); the worst was Q4 2025 (a decline of 70.1%).
- Per Business Quant data, MNPR's Share-based Compensation in the three quarters before Q4 2025 was $1.1 million (Q3 2025), $1.28 million (Q2 2025) and $1.36 million (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Monopar Therapeutics | 715.17 Mn | 433.40 Mn | - | - |
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 1.10 Mn |
| Sep 30, 2025 | 1.10 Mn |
| Jun 30, 2025 | 1.28 Mn |
| Mar 31, 2025 | 1.36 Mn |
| Dec 31, 2024 | 3.69 Mn |
| Sep 30, 2024 | 199,122.00 |
| Jun 30, 2024 | 334,390.00 |
| Mar 31, 2024 | 328,661.00 |
| Dec 31, 2023 | 474,206.00 |
| Sep 30, 2023 | 474,138.00 |
| Jun 30, 2023 | 473,296.00 |
| Mar 31, 2023 | 476,209.00 |
| Dec 31, 2022 | 393,417.00 |
| Sep 30, 2022 | 390,741.00 |
| Jun 30, 2022 | 357,293.00 |
| Mar 31, 2022 | 499,812.00 |
| Dec 31, 2021 | 350,164.00 |
| Sep 30, 2021 | 392,065.00 |
| Jun 30, 2021 | 357,593.00 |
| Mar 31, 2021 | 368,232.00 |
Monopar Therapeutics Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=MNPR&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "MNPR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=MNPR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();